Rossari Biotech Limited — Others, 21-10-2024: Copy of Newspaper Publication

Rossari Biotech Limited has published consolidated unaudited financial results for the quarter and half-year ending September 30, 2024. Total income from operations was ₹9,880.01 million, with a net profit after tax of ₹702.32 million. Earnings per share (EPS) for the quarter stood at ₹6.39 (basic) and ₹6.38 (diluted). The results have been approved by the Board of Directors and are available on the company's website and stock exchanges.